List of Excipients in API zafirlukast
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing zafirlukast
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Major Pharmaceuticals | ZAFIRLUKAST | zafirlukast | 0904-6646 | CELLULOSE, MICROCRYSTALLINE | |
Major Pharmaceuticals | ZAFIRLUKAST | zafirlukast | 0904-6646 | CROSCARMELLOSE SODIUM | |
Major Pharmaceuticals | ZAFIRLUKAST | zafirlukast | 0904-6646 | HYPROMELLOSE | |
Major Pharmaceuticals | ZAFIRLUKAST | zafirlukast | 0904-6646 | LACTOSE | |
Major Pharmaceuticals | ZAFIRLUKAST | zafirlukast | 0904-6646 | MAGNESIUM STEARATE | |
Major Pharmaceuticals | ZAFIRLUKAST | zafirlukast | 0904-6646 | POVIDONE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing zafirlukast
Detailed excipient profiles for zafirlukast
Excipient focus: ANHYDROUS LACTOSE
zafirlukast drug variants containing ANHYDROUS LACTOSE
Company | Ingredient | NDC |
---|---|---|
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing ANHYDROUS LACTOSE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
AvPAK | zafirlukast | 50268-805 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
zafirlukast drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | zafirlukast | 53808-0203 |
Aurobindo Pharma Limited | zafirlukast | 59651-291 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
zafirlukast drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
AvPAK | zafirlukast | 50268-805 |
Dr Reddys Laboratories Limited | zafirlukast | 55111-625 |
American Health Packaging | zafirlukast | 68084-059 |
Carilion Materials Management | zafirlukast | 68151-1977 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
zafirlukast drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
AvPAK | zafirlukast | 50268-805 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
zafirlukast drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
AvPAK | zafirlukast | 50268-805 |
Dr Reddys Laboratories Limited | zafirlukast | 55111-625 |
American Health Packaging | zafirlukast | 68084-059 |
Carilion Materials Management | zafirlukast | 68151-1977 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
zafirlukast drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
State of Florida DOH Central Pharmacy | zafirlukast | 53808-0203 |
Bryant Ranch Prepack | zafirlukast | 63629-2102 |
Strides Pharma Science Limited | zafirlukast | 64380-177 |
Bryant Ranch Prepack | zafirlukast | 72162-2362 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
AvPAK | zafirlukast | 50268-805 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
zafirlukast drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvPAK | zafirlukast | 50268-805 |
Dr Reddys Laboratories Limited | zafirlukast | 55111-625 |
Aurobindo Pharma Limited | zafirlukast | 59651-291 |
American Health Packaging | zafirlukast | 68084-059 |
Carilion Materials Management | zafirlukast | 68151-1977 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
State of Florida DOH Central Pharmacy | zafirlukast | 53808-0203 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
zafirlukast drug variants containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
Strides Pharma Science Limited | zafirlukast | 64380-187 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvPAK | zafirlukast | 50268-805 |
State of Florida DOH Central Pharmacy | zafirlukast | 53808-0203 |
Dr Reddys Laboratories Limited | zafirlukast | 55111-625 |
Aurobindo Pharma Limited | zafirlukast | 59651-291 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE
zafirlukast drug variants containing LACTOSE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
Bryant Ranch Prepack | zafirlukast | 63629-2102 |
Strides Pharma Science Limited | zafirlukast | 64380-177 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
zafirlukast drug variants containing LACTOSE MONOHYDRATE
zafirlukast drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
Bryant Ranch Prepack | zafirlukast | 63629-2102 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
zafirlukast drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
zafirlukast drug variants containing MICROCRYSTALLINE CELLULOSE 101
Company | Ingredient | NDC |
---|---|---|
Aurobindo Pharma Limited | zafirlukast | 59651-291 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
zafirlukast drug variants containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Aurobindo Pharma Limited | zafirlukast | 59651-291 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
zafirlukast drug variants containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
AvPAK | zafirlukast | 50268-805 |
Dr Reddys Laboratories Limited | zafirlukast | 55111-625 |
American Health Packaging | zafirlukast | 68084-059 |
Carilion Materials Management | zafirlukast | 68151-1977 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
State of Florida DOH Central Pharmacy | zafirlukast | 53808-0203 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
zafirlukast drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
State of Florida DOH Central Pharmacy | zafirlukast | 53808-0203 |
Bryant Ranch Prepack | zafirlukast | 63629-2102 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvPAK | zafirlukast | 50268-805 |
Dr Reddys Laboratories Limited | zafirlukast | 55111-625 |
Aurobindo Pharma Limited | zafirlukast | 59651-291 |
American Health Packaging | zafirlukast | 68084-059 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
zafirlukast drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
Aurobindo Pharma Limited | zafirlukast | 59651-291 |
Bryant Ranch Prepack | zafirlukast | 72162-2361 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
AvPAK | zafirlukast | 50268-805 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K60
zafirlukast drug variants containing POVIDONE K60
Company | Ingredient | NDC |
---|---|---|
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing POVIDONE K60
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
AvPAK | zafirlukast | 50268-805 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
zafirlukast drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
AvPAK | zafirlukast | 50268-805 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
zafirlukast drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
AvPAK | zafirlukast | 50268-805 |
Dr Reddys Laboratories Limited | zafirlukast | 55111-625 |
American Health Packaging | zafirlukast | 68084-059 |
Carilion Materials Management | zafirlukast | 68151-1977 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
zafirlukast drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | zafirlukast | 0904-6646 |
Rising Pharmaceuticals Inc | zafirlukast | 16571-654 |
Camber Pharmaceuticals Inc | zafirlukast | 31722-007 |
AvKARE | zafirlukast | 42291-970 |
Par Pharmaceutical Inc | zafirlukast | 49884-549 |
Par Pharmaceutical Inc | zafirlukast | 49884-589 |
>Company | >Ingredient | >NDC |
zafirlukast drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.